{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:42:45Z","timestamp":1759920165560,"version":"build-2065373602"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Ruijin Hospital Nursing Specialized Fund","award":["RJKH(Y)-2025-018"],"award-info":[{"award-number":["RJKH(Y)-2025-018"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82470433","82070358"],"award-info":[{"award-number":["82470433","82070358"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-025-02948-6","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:07:32Z","timestamp":1759918052000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Plasma ALKAL2 levels are associated with coronary atherosclerosis in patients with type 2 diabetes mellitus"],"prefix":"10.1186","volume":"24","author":[{"given":"Yipaerguli","family":"Maimaiti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minhui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feifei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingmeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinrui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiujing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weifeng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fenghua","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"issue":"19","key":"2948_CR1","doi-asserted-by":"publisher","first-page":"e779","DOI":"10.1161\/CIR.0000000000000766","volume":"141","author":"SV Arnold","year":"2020","unstructured":"Arnold SV, Bhatt DL, Barsness GW, Beatty AL, Deedwania PC, Inzucchi SE, et al. Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: A scientific statement from the American heart association. Circulation. 2020;141(19):e779\u2013806.","journal-title":"Circulation"},{"issue":"9548","key":"2948_CR2","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1016\/S0140-6736(06)69700-6","volume":"368","author":"G Danaei","year":"2006","unstructured":"Danaei G, Lawes CM, Vander Hoorn S, Murray CJ, Ezzati M. Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment. Lancet. 2006;368(9548):1651\u20139.","journal-title":"Lancet"},{"key":"2948_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpc.2022.100335","volume":"10","author":"ND Wong","year":"2022","unstructured":"Wong ND, Budoff MJ, Ferdinand K, Graham IM, Michos ED, Reddy T, et al. Atherosclerotic cardiovascular disease risk assessment: an American society for preventive cardiology clinical practice statement. Am J Prev Cardiol. 2022;10:100335.","journal-title":"Am J Prev Cardiol"},{"issue":"Suppl 1","key":"2948_CR4","first-page":"S103","volume":"42","author":"10","year":"2019","unstructured":"10. Cardiovascular disease and risk management: standards of medical care in Diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S103\u201323.","journal-title":"Diabetes Care"},{"issue":"1","key":"2948_CR5","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2337\/dc23-1198","volume":"47","author":"T Avdic","year":"2024","unstructured":"Avdic T, Carlsen HK, Isaksson R, Gudbj\u00f6rnsdottir S, Mandalenakis Z, Franz\u00e9n S, et al. Risk factors for and risk of peripheral artery disease in Swedish individuals with type 2 diabetes: a nationwide register-based study. Diabetes Care. 2024;47(1):109\u201316.","journal-title":"Diabetes Care"},{"issue":"9","key":"2948_CR6","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/nrcardio.2010.104","volume":"7","author":"JM Ordov\u00e1s","year":"2010","unstructured":"Ordov\u00e1s JM, Smith CE. Epigenetics and cardiovascular disease. Nat Rev Cardiol. 2010;7(9):510\u20139.","journal-title":"Nat Rev Cardiol"},{"key":"2948_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241813723","author":"A Wo\u0142owiec","year":"2023","unstructured":"Wo\u0142owiec A, Wo\u0142owiec \u0141, Grze\u015bk G, Ja\u015bniak A, Osiak J, Husejko J, et al. The role of selected epigenetic pathways in cardiovascular diseases as a potential therapeutic target. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241813723.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"2948_CR8","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.jacbts.2018.05.003","volume":"3","author":"MB Felisbino","year":"2018","unstructured":"Felisbino MB, McKinsey TA. Epigenetics in cardiac fibrosis: emphasis on inflammation and fibroblast activation. JACC Basic Transl Sci. 2018;3(5):704\u201315.","journal-title":"JACC Basic Transl Sci"},{"issue":"7","key":"2948_CR9","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1161\/CIRCRESAHA.124.325402","volume":"136","author":"R Ghazal","year":"2025","unstructured":"Ghazal R, Wang M, Liu D, Tschumperlin DJ, Pereira NL. Cardiac fibrosis in the multi-omics era: implications for heart failure. Circ Res. 2025;136(7):773\u2013802.","journal-title":"Circ Res"},{"key":"2948_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25084224","author":"G Pepe","year":"2024","unstructured":"Pepe G, Appierdo R, Ausiello G, Helmer-Citterich M, Gherardini PF. A meta-analysis approach to gene regulatory network inference identifies key regulators of cardiovascular diseases. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25084224.","journal-title":"Int J Mol Sci"},{"issue":"24","key":"2948_CR11","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1161\/CIRCULATIONAHA.123.067587","volume":"149","author":"H Pan","year":"2024","unstructured":"Pan H, Ho SE, Xue C, Cui J, Johanson QS, Sachs N, et al. Atherosclerosis is a smooth muscle cell-driven tumor-like disease. Circulation. 2024;149(24):1885\u201398.","journal-title":"Circulation"},{"issue":"12","key":"2948_CR12","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/s41569-019-0227-9","volume":"16","author":"GL Basatemur","year":"2019","unstructured":"Basatemur GL, J\u00f8rgensen HF, Clarke MCH, Bennett MR, Mallat Z. Vascular smooth muscle cells in atherosclerosis. Nat Rev Cardiol. 2019;16(12):727\u201344.","journal-title":"Nat Rev Cardiol"},{"issue":"12","key":"2948_CR13","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1038\/labinvest.3700348","volume":"85","author":"M Marzec","year":"2005","unstructured":"Marzec M, Kasprzycka M, Ptasznik A, Wlodarski P, Zhang Q, Odum N, et al. Inhibition of ALK enzymatic activity in T-cell lymphoma cells induces apoptosis and suppresses proliferation and STAT3 phosphorylation independently of Jak3. Lab Invest. 2005;85(12):1544\u201354.","journal-title":"Lab Invest"},{"issue":"50","key":"2948_CR14","doi-asserted-by":"publisher","first-page":"7386","DOI":"10.1038\/sj.onc.1204870","volume":"20","author":"C Greenland","year":"2001","unstructured":"Greenland C, Touriol C, Chevillard G, Morris SW, Bai R, Duyster J, et al. Expression of the oncogenic NPM-ALK chimeric protein in human lymphoid T-cells inhibits drug-induced, but not Fas-induced apoptosis. Oncogene. 2001;20(50):7386\u201397.","journal-title":"Oncogene"},{"issue":"40","key":"2948_CR15","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ado8366","volume":"10","author":"N Wu","year":"2024","unstructured":"Wu N, Li J, Li L, Yang L, Dong L, Shen C, et al. MerTK(+) macrophages promote melanoma progression and immunotherapy resistance through AhR-ALKAL1 activation. Sci Adv. 2024;10(40):eado8366.","journal-title":"Sci Adv"},{"issue":"1","key":"2948_CR16","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.bbrc.2018.04.226","volume":"501","author":"B Zhang","year":"2018","unstructured":"Zhang B, Wei W, Qiu J. ALK is required for NLRP3 inflammasome activation in macrophages. Biochem Biophys Res Commun. 2018;501(1):246\u201352.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"2948_CR17","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1080\/15548627.2023.2259216","volume":"20","author":"Z Xu","year":"2024","unstructured":"Xu Z, Pan Z, Jin Y, Gao Z, Jiang F, Fu H, et al. Inhibition of PRKAA\/AMPK (Ser485\/491) phosphorylation by crizotinib induces cardiotoxicity via perturbing autophagosome-lysosome fusion. Autophagy. 2024;20(2):416\u201336.","journal-title":"Autophagy"},{"issue":"3","key":"2948_CR18","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1158\/1541-7786.MCR-18-1075","volume":"17","author":"LE Davis","year":"2019","unstructured":"Davis LE, Nusser KD, Przybyl J, Pittsenbarger J, Hofmann NE, Varma S, et al. Discovery and characterization of recurrent, targetable ALK fusions in leiomyosarcoma. Mol Cancer Res. 2019;17(3):676\u201385.","journal-title":"Mol Cancer Res"},{"issue":"1","key":"2948_CR19","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/s41467-024-45215-0","volume":"15","author":"C Liu","year":"2024","unstructured":"Liu C, Zhou C, Xia W, Zhou Y, Qiu Y, Weng J, et al. Targeting ALK averts ribonuclease 1-induced immunosuppression and enhances antitumor immunity in hepatocellular carcinoma. Nat Commun. 2024;15(1):1009.","journal-title":"Nat Commun"},{"key":"2948_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2025.156905","volume":"190","author":"X Feng","year":"2025","unstructured":"Feng X, Lu J, Cheng W, Zhao P, Chang X, Wu J. LTK deficiency induces macrophage M2 polarization and ameliorates Sjogren\u2019s syndrome by reducing chemokine CXCL13. Cytokine. 2025;190:156905.","journal-title":"Cytokine"},{"issue":"5","key":"2948_CR21","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s40291-023-00659-w","volume":"27","author":"S Arslan","year":"2023","unstructured":"Arslan S, \u015eahin N, Bayyurt B, Berkan \u00d6, Y\u0131lmaz MB, A\u015fam M, et al. Role of lncRNAs in remodeling of the coronary artery plaques in patients with atherosclerosis. Mol Diagn Ther. 2023;27(5):601\u201310.","journal-title":"Mol Diagn Ther"},{"issue":"52","key":"2948_CR22","doi-asserted-by":"publisher","first-page":"15862","DOI":"10.1073\/pnas.1520099112","volume":"112","author":"AV Reshetnyak","year":"2015","unstructured":"Reshetnyak AV, Murray PB, Shi X, Mo ES, Mohanty J, Tome F, et al. Augmentor \u03b1 and \u03b2 (FAM150) are ligands of the receptor tyrosine kinases ALK and LTK: hierarchy and specificity of ligand-receptor interactions. Proc Natl Acad Sci U S A. 2015;112(52):15862\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"26","key":"2948_CR23","doi-asserted-by":"publisher","first-page":"3821","DOI":"10.1038\/sj.onc.1202736","volume":"18","author":"H Honda","year":"1999","unstructured":"Honda H, Harada K, Komuro I, Terasaki F, Ueno H, Tanaka Y, et al. Heart-specific activation of LTK results in cardiac hypertrophy, cardiomyocyte degeneration and gene reprogramming in transgenic mice. Oncogene. 1999;18(26):3821\u201330.","journal-title":"Oncogene"},{"issue":"6","key":"2948_CR24","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","volume":"42","author":"AV Chobanian","year":"2003","unstructured":"Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr., et al. Seventh report of the joint National committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42(6):1206\u201352.","journal-title":"Hypertension"},{"issue":"25","key":"2948_CR25","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","volume":"106","author":"Third Report of the National Cholesterol Education Program (NCEP)","year":"2002","unstructured":"Third Report of the National Cholesterol Education Program (NCEP). Expert panel on Detection, Evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III) final report. Circulation. 2002;106(25):3143\u2013421.","journal-title":"Circulation"},{"key":"2948_CR26","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.atherosclerosis.2019.05.012","volume":"287","author":"GP Rampidis","year":"2019","unstructured":"Rampidis GP, Benetos G, Benz DC, Giannopoulos AA, Buechel RR. A guide for Gensini score calculation. Atherosclerosis. 2019;287:181\u20133.","journal-title":"Atherosclerosis"},{"key":"2948_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/jcdd9050157","author":"J Liu","year":"2022","unstructured":"Liu J, Chen Q, Lu L, Jin Q, Bao Y, Ling T, et al. Association of circulating IgE and CML levels with in-stent restenosis in type 2 diabetic patients with stable coronary artery disease. J Cardiovasc Dev Dis. 2022. https:\/\/doi.org\/10.3390\/jcdd9050157.","journal-title":"J Cardiovasc Dev Dis"},{"issue":"24","key":"2948_CR28","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.027614","volume":"11","author":"S Chen","year":"2022","unstructured":"Chen S, Li LY, Wu ZM, Liu Y, Li FF, Huang K, et al. SerpinG1: a novel biomarker associated with poor coronary collateral in patients with stable coronary disease and chronic total occlusion. J Am Heart Assoc. 2022;11(24):e027614.","journal-title":"J Am Heart Assoc"},{"key":"2948_CR29","doi-asserted-by":"crossref","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312.","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"key":"2948_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1475-2840-5-27","volume":"5","author":"LJ Pu","year":"2006","unstructured":"Pu LJ, Lu L, Xu XW, Zhang RY, Zhang Q, Zhang JS, et al. Value of serum glycated albumin and high-sensitivity C-reactive protein levels in the prediction of presence of coronary artery disease in patients with type 2 diabetes. Cardiovasc Diabetol. 2006;5:27.","journal-title":"Cardiovasc Diabetol"},{"issue":"9","key":"2948_CR31","doi-asserted-by":"publisher","first-page":"5881","DOI":"10.1021\/acs.chemrev.8b00467","volume":"119","author":"MD Paul","year":"2019","unstructured":"Paul MD, Hristova K. The RTK interactome: overview and perspective on RTK heterointeractions. Chem Rev. 2019;119(9):5881\u2013921.","journal-title":"Chem Rev"},{"issue":"19","key":"2948_CR32","doi-asserted-by":"publisher","first-page":"3693","DOI":"10.1111\/febs.13342","volume":"282","author":"MK Chen","year":"2015","unstructured":"Chen MK, Hung MC. Proteolytic cleavage, trafficking, and functions of nuclear receptor tyrosine kinases. FEBS J. 2015;282(19):3693\u2013721.","journal-title":"FEBS J"},{"issue":"6","key":"2948_CR33","doi-asserted-by":"publisher","first-page":"e446","DOI":"10.1002\/mco2.446","volume":"4","author":"N Zhang","year":"2023","unstructured":"Zhang N, Li Y. Receptor tyrosine kinases: biological functions and anticancer targeted therapy. MedComm (2020). 2023;4(6):e446.","journal-title":"MedComm (2020)"},{"key":"2948_CR34","doi-asserted-by":"publisher","first-page":"1404253","DOI":"10.3389\/fcvm.2024.1404253","volume":"11","author":"KAK Mohammed","year":"2024","unstructured":"Mohammed KAK, Madeddu P, Avolio E. MEK inhibitors: a promising targeted therapy for cardiovascular disease. Front Cardiovasc Med. 2024;11:1404253.","journal-title":"Front Cardiovasc Med"},{"key":"2948_CR35","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a009183","author":"M Jeltsch","year":"2013","unstructured":"Jeltsch M, Lepp\u00e4nen VM, Saharinen P, Alitalo K. Receptor tyrosine kinase-mediated angiogenesis. Cold Spring Harb Perspect Biol. 2013. https:\/\/doi.org\/10.1101\/cshperspect.a009183.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"4","key":"2948_CR36","doi-asserted-by":"publisher","first-page":"4341","DOI":"10.1080\/02648725.2023.2210449","volume":"40","author":"B Lei","year":"2024","unstructured":"Lei B, Wu H, You G, Wan X, Chen S, Chen L, et al. Silencing of ALOX15 reduces ferroptosis and inflammation induced by cerebral ischemia-reperfusion by regulating PHD2\/HIF2\u03b1 signaling pathway. Biotechnol Genet Eng Rev. 2024;40(4):4341\u201360.","journal-title":"Biotechnol Genet Eng Rev"},{"key":"2948_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12020426","author":"L Wang","year":"2020","unstructured":"Wang L, Lui VWY. Emerging roles of ALK in immunity and insights for immunotherapy. Cancers (Basel). 2020. https:\/\/doi.org\/10.3390\/cancers12020426.","journal-title":"Cancers (Basel)"},{"key":"2948_CR38","doi-asserted-by":"crossref","unstructured":"Andraos E, Dignac J, Meggetto F, NPM-ALK. A driver of lymphoma pathogenesis and a therapeutic target. Cancers (Basel). 2021;13(1).","DOI":"10.3390\/cancers13010144"},{"key":"2948_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/biom13101490","author":"L Katic","year":"2023","unstructured":"Katic L, Priscan A. Multifaceted roles of ALK family receptors and augmentor ligands in health and disease: a comprehensive review. Biomolecules. 2023. https:\/\/doi.org\/10.3390\/biom13101490.","journal-title":"Biomolecules"},{"issue":"16","key":"2948_CR40","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2200476119","volume":"119","author":"M Ahmed","year":"2022","unstructured":"Ahmed M, Kaur N, Cheng Q, Shanabrough M, Tretiakov EO, Harkany T, et al. A hypothalamic pathway for augmentor \u03b1-controlled body weight regulation. Proc Natl Acad Sci U S A. 2022;119(16):e2200476119.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2948_CR41","doi-asserted-by":"publisher","DOI":"10.1172\/JCI154317","author":"M Defaye","year":"2022","unstructured":"Defaye M, Iftinca MC, Gadotti VM, Basso L, Abdullah NS, Cum\u00e9nal M, et al. The neuronal tyrosine kinase receptor ligand ALKAL2 mediates persistent pain. J Clin Invest. 2022. https:\/\/doi.org\/10.1172\/JCI154317.","journal-title":"J Clin Invest"},{"key":"2948_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24065378","author":"CA Reynolds","year":"2023","unstructured":"Reynolds CA, Minic Z. Chronic pain-associated cardiovascular disease: the role of sympathetic nerve activity. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24065378.","journal-title":"Int J Mol Sci"},{"key":"2948_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11081074","volume":"11","author":"SP Ducray","year":"2019","unstructured":"Ducray SP, Natarajan K, Garland GD, Turner SD, Egger G. The transcriptional roles of ALK fusion proteins in tumorigenesis. Cancers (Basel). 2019;11:8.","journal-title":"Cancers (Basel)"},{"issue":"10","key":"2948_CR44","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nrc3580","volume":"13","author":"B Hallberg","year":"2013","unstructured":"Hallberg B, Palmer RH. Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology. Nat Rev Cancer. 2013;13(10):685\u2013700.","journal-title":"Nat Rev Cancer"},{"key":"2948_CR45","doi-asserted-by":"publisher","first-page":"858279","DOI":"10.3389\/fphar.2022.858279","volume":"13","author":"Y Liu","year":"2022","unstructured":"Liu Y, Chen C, Rong C, He X, Chen L. Anaplastic lymphoma kinase tyrosine kinase inhibitor-associated cardiotoxicity: a recent five-year pharmacovigilance study. Front Pharmacol. 2022;13:858279.","journal-title":"Front Pharmacol"},{"key":"2948_CR46","doi-asserted-by":"publisher","first-page":"107319","DOI":"10.1016\/j.lungcan.2023.107319","volume":"184","author":"Y Luo","year":"2023","unstructured":"Luo Y, Zhang Z, Guo X, Tang X, Li S, Gong G, et al. Comparative safety of anaplastic lymphoma kinase tyrosine kinase inhibitors in advanced anaplastic lymphoma kinase-mutated non-small cell lung cancer: systematic review and network meta-analysis. Lung Cancer. 2023;184:107319.","journal-title":"Lung Cancer"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02948-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-025-02948-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02948-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:07:34Z","timestamp":1759918054000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-025-02948-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2948"],"URL":"https:\/\/doi.org\/10.1186\/s12933-025-02948-6","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,8]]},"assertion":[{"value":"4 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"388"}}